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and Genetics, House Ear Institute, Los Angeles, CaliforniaABSTRACT Cochlear outer hair cells undergo reversible changes in shape when externally stimulated. This response, known
as OHC motility, is a central component of the cochlear amplifier, the mechanism responsible for the high sensitivity of mamma-
lian hearing. We report that actin depolymerization, as regulated by activation/inhibition of LIMK/cofilin-mediated pathways, has
a pivotal role in OHC motility. LIMK-mediated cofilin phosphorylation, which inhibits the actin depolymerizing activity of this
protein, increases both electromotile amplitude and total length of guinea pig OHCs. In contrast, a decrease in cofilin phosphor-
ylation reduces both OHC electromotile amplitude and OHC length. Experiments with acetylcholine and lysophosphatidic acid
indicate that the effects of these agents on OHC motility are associated with regulation of cofilin phosphorylation via different
signaling cascades. On the other hand, nonlinear capacitance measurements confirmed that all observed changes in OHC
motile response were independent of the performance of the motor protein prestin. Altogether, these results strongly support
the hypothesis that the cytoskeleton has a major role in the regulation of OHC motility, and identify actin depolymerization as
a key process for modulating cochlear amplification.INTRODUCTIONOuter hair cells (OHCs) elongate and shorten in response to
electrical stimulation by activating a plasma membrane-
based force generator mechanism associated with confor-
mational changes in the integral membrane protein prestin
(1,2). A variety of mechanical and chemical stimuli, on the
other hand, induce changes in OHCs’ length by activating
a prestin-independent mechanism associated with cyto-
skeletal reorganization (1,3). The prestin-dependent (elec-
tromotility) and the prestin-independent (slow motility)
mechanisms, working alone or in combination and perhaps
in association with an active hair bundle motion, are part of
the cochlear amplifier, the active mechanism enhancing
sensitivity and frequency discrimination of the mammalian
ear (1).
OHCs possess a cortical cytoskeleton lying underneath
the lateral plasma membrane. It is mainly composed of cir-
cumferentially oriented actin filaments cross-linked by
spectrin tetramers and linked to the plasma membrane by
thousands of ~25-nm long, 10-nm diameter pillars (3). It has
been suggested that the cortical cytoskeleton provides the
vectorial component to the forces generated by prestin
molecules in the lateral plasma membrane of OHCs (3,4),
and that it could be involved in the regulation of their motile
responses (5,6).
Rho GTPases are crucial regulators of the actin cytoskel-
eton known to mediate in different types of cell motility.
Previous results from our laboratory suggested that cytoskel-
etal changes mediated by Rho GTPases are part of a cellular
mechanism of homeostatic control of OHC motility (5,6).Submitted April 15, 2010, and accepted for publication August 13, 2010.
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0006-3495/10/10/2067/10 $2.00Acetylcholine (ACh), the major neurotransmitter released
by efferent terminals at the base of OHCs (7), was reported
to affect OHC motility (8,9) by activating a Rho Kinase
(ROCK)-independent pathway (5,6). Lysophosphatidic
acid (LPA)—a lipid mediator with diverse biological activi-
ties—is known to influence cell motility in several cell
systems by activating RhoA-, Rac1-, and Cdc42-mediated
pathways (10). Thus, ACh and LPA are two important tools
to investigate the role of the cytoskeleton and Rho-mediated
signals in the regulation of OHC motility.
As potent regulators of actin dynamics and recognized
targets of Rho GTPases, LIM-kinases (LIMK) are potential
cytoskeletal effectors of signaling cascades involved in the
regulation of OHC motility (11). The two known members
of the LIMK family, LIMK1 and LIMK2, display cell
type-specific expression levels and different subcellular
localization (12,13). LIMK are phosphorylated by RhoA
via ROCK-mediated signals, and by Cdc42 through the
myotonic dystrophy kinase-related Cdc42-binding kinase
(MRCKa) (11). In addition, Rac1 and Cdc42 phosphorylate
LIMK1 through p21-activated kinases (11). Both LIMK
exert their effect via phosphorylating—and thus inactivat-
ing—cofilin, a small protein with actin depolymerizing
activity (14). Cells lacking cofilin have impaired locomo-
tion; those overexpressing cofilin are more motile (15).
We have investigated the expression and functional role
of LIMK and cofilin in guinea pig OHCs. LIMK2 was found
expressed both at the cell body and the hair bundle of iso-
lated OHCs, whereas LIMK1 was abundant at the cell
body but absent at the OHCs’ stereocilia. We also found
that both ACh and LPA stimulate cofilin phosphorylation
in OHCs. In addition, our findings indicate LIMK-mediated
cofilin phosphorylation, and hence actin depolymerization,doi: 10.1016/j.bpj.2010.08.015
2068 Matsumoto et al.would regulate different aspects of OHC motility and
cochlear amplification. Thus, any disruption in the signaling
pathways involving these molecules could result in extreme
physiological responses such as hyperacusis or deafness.MATERIALS AND METHODS
Isolation of outer hair cells
Cochleae were obtained from young guinea pigs (Cavia porcellus, 200–
300 g) euthanized with CO2 with procedures approved by the Institutional
Animal Care and Use Committee. Cochlear spirals were placed in Leibo-
witz L-15 (Gibco-Invitrogen, Grand Island, NY) containing 1 mg/mL colla-
genase (type IV; Sigma, St. Louis, MO), and incubated at 31C for 3 min.
The organ of Corti was removed from the bone with fine needles and OHCs
were mechanically dissociated by reflux through the needle of a 50 mL
syringe (Hamilton, Reno, NV). Isolated OHCs were then moved to
a recording chamber (PCCS1; Bioscience Tools, San Diego, CA) filled
with L-15, and observed with Nomarski differential interference contrast
optics on an Axiovert 135TV inverted microscope with a 63/1.2 C-Apo-
chromat objective (Carl Zeiss, Jena, Germany). Only OHCs meeting estab-
lished health criteria (16) were used in this study.Immunolabeling
Excised cochlear spirals were incubated for variable periods in either L-15
alone (control) or with the following agents (alone or combined): 10 mM
LPA (Sigma), 100 mM ACh (Sigma), 2 mg/mL cell permeable C3-trans-
ferase (Cytoskeleton, Denver, CO), 10 mM Y27632 (Upstate Biotech-
nology, Lake Placid, NY). OHCs dissociated from cochlear spirals were
moved to a petri dish with an uncoated glass bottom (MatTek, Ashland,
MA), fixed in 4% paraformaldehyde (EMS, Fort Washington, PA) in
phosphate-buffered saline for 2 h and processed for confocal microscopy.
Anti-LIMK1 (C-18), anti-LIMK2 (H-78 and C-19), anti-cofilin (N-19),
anti-phosphorylated cofilin (p-cofilin @ Ser3), anti-LPA2 (EDG-4, C-16),
anti-LPA3 (EDG-7, K-19) and anti-LPA4 (P2Y9, N-20) from Santa Cruz
Biotechnologies (Santa Cruz, CA), anti-p-LIMK1/LIMK2 (Thr508/Thr505)
from Cell Signaling Technology (Beverly, MA), and anti-LPA1 (EDG-2)
from Upstate Biotechnology were used as primary antibodies at 1:100/
1:200 dilutions. Cy3 and Cy2 from Jackson ImmunoResearch (West Grove,
PA), and Alexa 488 (Molecular Probes-Invitrogen, Eugene, OR) were used
as secondary antibodies at 1:500/1:1000 dilutions. Actin was stained with
rhodamine phalloidin (Molecular Probes). Samples were observed with
LSM-410 (Carl Zeiss) and TSC-SP5 Broadband Spectra (Leica, Wetzlar,
Germany) laser confocal microscopes, with C-Apo 63/1.2 and HCX-PL
63/1.2 objectives, respectively. For relative quantification of cofilin phos-
phorylation, green (p-cofilin) and red (cofilin) channels were evaluated
separately for every OHC with the Analysis feature in the Photoshop
CS4 Extended software (Adobe, San Jose, CA). By using the Lasso Tool
to define the borders of the OHC image and the integrated density (ID)
Tool from Photoshop to calculate the sum of the values of the pixels in
each separated channel in the selected OHC image, we were able to define
the ratio ID green/ID red as an estimation of the ratio p-cofilin-associated/
cofilin-associated fluorescence in each single cell in every experimental
condition. Values of at least 20 OHCs per condition were statistically
analyzed using analysis-of-variance techniques.Electrophysiology
Whole-cell voltage-clamp was achieved with either conventional or
nystatin-perforated patch techniques (17,18) at room temperature using
an EPC-9 patch-clamp amplifier (HEKA, Lambrecht, Germany). Both tech-
niques provided similar results, confirming OHCmotility experiments wereBiophysical Journal 99(7) 2067–2076not affected by washout of cytoplasmic components. Patch electrodes were
made from borosilicate capillary glass (G-1.5; Narishige, Tokyo, Japan)
using a P-97 micropipette puller (Sutter Instruments, Novato, CA). Contin-
uous perfusion of an external solution consisting of L-15 adjusted to 305–
310 mOsm with distilled water was provided at a rate of 0.3 mL/min using
a syringe pump. Internal (intrapipette) solution was composed of 150 mM
KCl, 1 mM MgCl2, 0.1 mM EGTA, 2 mM ATP-Mg, 0.1 mM GTP-Na, and
10 mM HEPES; pH was adjusted to 7.2 with Tris. Nystatin (Sigma) was
initially dissolved in acidified methanol at 10 mg/mL, and this stock solu-
tion was added to the internal solution at a final concentration of 200 mg/mL
just before use. Osmolarity of the intrapipette solution was adjusted to the
same value of the control extracellular solution by adding glucose. The
resistance between the patch electrode filled with this solution and the
bath solution was 4–6 MU. Measurements of voltage-dependent nonlinear
capacitance (NLC), the electrical signature of prestin (19), were performed
using the software lock-in amplifier function included in the Pulse software
(HEKA). Capacitance function was fitted to the first derivative of a two-
state Boltzmann function relating nonlinear charge to membrane voltage
(19). For capacitance measurements, OHCs were perfused with a blocking
solution containing 100 mM NaCl, 20 mM CsCl, 20 mM tetraethylammo-
nium-Cl, 2 mM CoCl2, 1.52 mM MgCl2, 5 mM glucose, and 10 mM
HEPES, adjusted to pH 7.2 with Tris. The intrapipette solution consisted
of 140 mM CsCl, 2 mM MgCl2, 10 mM EGTA, and 10 mM HEPES,
adjusted to pH 7.2 with Tris. Osmolarity of these solutions was adjusted
to 305–310 mOsm with glucose. Analysis-of-variance techniques were
used to evaluate the effects of pharmacological agents.Pharmacological agents
ACh and LPA were used as activator of Rho GTPases, cell permeable
C3-tranferase as RhoA inhibitor, Y27632 as ROCK inhibitor, and peptides
S3 (MASGVAVSDGVIKVFN) and S3-RV (NFVKIVGDSVAVGSAM)
(SigmaGenosys,Woodlands, TX), as a competitive inhibitor of cofilin phos-
phorylation and its control, respectively (20). In addition, latrunculin-A
(Sigma) was used as an agent to prevent actin polymerization. For motility
experiments, Y27632 (5 mM), S3 (5 mg/mL), and S3-RV (5 mg/mL) were
included in the pipette solution, thus these drugs started causing effect
only after the whole-cell patch-clamp was obtained. LPA (10 mM) and
ACh (100 mM), in contrast, were added to the cells’ external media through
the perfusion system typically 4min beforemembrane rupture (exceptwhere
specifically indicated). OHCs were electrically stimulated every 2 min, with
the first pulse given 60 s after membrane rupture. We set the time of the first
electrical stimulation as time 0 for electromotility measurements.Video analysis and data handling
Images of isolated OHCs were captured and analyzed by using two different
experimental approaches. In a first approach, images were captured in
QuickTime (Apple, Cupertino, CA) video format at standard video resolu-
tion (720 480 pixels) and frame rate (30 fps), and analyzed off-line using
DIAS software (Soll Technologies, Iowa City, IA) as previously described
(21,22). In a second approach, images were captured in AVI format at
higher resolution (1024 1024 pixels) and frequencies (60–1000 fps) using
the high speed Photron Fastcam X 1024 PCI camera (Photron, San Diego,
CA) and the High-Power LED Illumination System-36AD3500 (Light-
speed Technologies, Campbell, CA). Images were analyzed off-line using
ProAnalyst software (Xcitex, Cambridge, MA). Data was further processed
using Excel (Microsoft, Redmond,WA) and IGOR Pro (WaveMetrics, Lake
Oswego, OR) software.Analysis of electromotility and slow OHC motility
Electromotility and slow OHC motility were investigated with separate
protocols. For electromotility experiments, isolated OHCs underwent
Cytoskeletal Regulation of OHC Motility 2069electrical stimulations under the voltage-clamp protocol (Fig. S1 Aa in the
Supporting Material). The overlap of current traces (Fig. S1 B, inset) indi-
cated absence of electrophysiological degradation during the course of
experiments. The absence of a significant contribution of prestin-indepen-
dent mechanisms was confirmed by extraction analysis (21) (Fig. S1 D).
For analysis of slow OHC motility, cell length was monitored at a constant
VH ¼ 70 mV value to guarantee the absence of voltage-dependent contri-
butions. Values were expressed as a ratio to the cell length just before the
disruption of the membrane for whole-cell voltage clamp (Fig. S1 C).
Although in individual cases (e.g., Fig. S1 C, inset) cell length remained
near constant for 20 or more min, variability increased with time suggesting
cell deterioration (Fig. S1 Cb). Our studies indicated that, under our exper-
imental conditions, cell length data collected more than 10 min after
membrane rupture was less reliable. Therefore, only results corresponding
to the first 10 min of every experiment are being reported in this study.RESULTS
Guinea pig OHCs express LIMK1, LIMK2, cofilin,
LPA1, and LPA4
Strong immunolabeling of LIMK1, LIMK2, and cofilin was
observed in guinea pig OHCs by confocal microscopy
(Fig. 1 A). LIMK2 labeling was present throughout the
cell body, including the hair bundle. LIMK1 labeling, in
contrast, was abundant in the cell body but not evident at
the hair bundle. Cofilin and phosphorylated cofilin (p-cofi-
lin) distributions were similar throughout the OHCs, coloc-
alizing along the body of untreated cells and labeling
distinctly the hair bundle, the cuticular plate, the lateralcortex, and the actin-rich infracuticular structure. Antibody
specificity was evaluated by preadsorption with specific
peptides (Fig. S2).
All LPA activities in mammals are mediated by, at least,
five G-protein-coupled receptors: LPA1, LPA2, LPA3,
LPA4, and LPA5 (23). In OHCs we detected strong reac-
tivity to antibodies against LPA1 and LPA4, but not LPA2
and LPA3 (Fig. 1 B). Expression of LPA5 was not investi-
gated because of lack of reliable antibodies. Labeling of
LPA1 was observed at the lateral surface of OHCs and the
cytoplasm, but not at the apical plasma membrane, hair
bundle, or nucleus. LPA4 labeling, in contrast, was also
observed at the apical plasma membrane and nucleus
(Fig. 1 B).ACh and LPA stimulate LIMK-mediated cofilin
phosphorylation
We used anti-cofilin and anti-p-cofilin antibodies in OHCs
exposed to ACh and LPA. Exposure of isolated OHCs to
ACh for 30 min significantly increased the ratio p-cofilin/
cofilin immunoreactivity respect to the same ratio in nonex-
posed (control) cells (ACh ¼ 12.7 5 2.9 versus control ¼
1.8 5 0.2, p % 0.0001. Fig. 1 C, left). ACh-induced
increase in p-cofilin/cofilin ratio was prevented by pre-
and/or simultaneous incubation with the RhoA inhibitor
C3-transferase (0.22 5 0.03, p % 0.16 versus control.FIGURE 1 Immunolocalization of LIMK1,
LIMK2, cofilin, and LPA receptors in isolated
guinea pig OHCs. (A) LIMK1 and LIMK2 labeling
was strong in the cell soma. In the hair bundle, in
contrast, only LIMK2 was detected. Cofilin and
p-cofilin showed a similar, widespread distribu-
tion. (B) LPA1 and LPA4, but not LPA2 and
LPA3, are abundantly expressed in guinea pig
OHCs. (Red, rhodamine phalloidin.) (C) Exposure
to ACh increased cofilin phosphorylation (left).
ACh effect was inhibited by C3 (center) but not
by Y27632 (right). (D) LPA induced a generalized
increase in cofilin phosphorylation (left). Exposure
to LPAþC3 (center) and LPAþY27632 (right)
resulted in redistribution of p-cofilin labeling,
which concentrate at the hair bundle, cuticular
plate, nucleus, and infranuclear region.
Biophysical Journal 99(7) 2067–2076
2070 Matsumoto et al.Fig. 1 C, center) but not by the ROCK inhibitor Y27632
(6.7 5 0.5, p% 0.0001 versus control. Fig. 1 C, right).
LPA also increased the p-cofilin/cofilin ratio (Fig. 1 D,
left), but not as much as ACh (5.35 0.4, p% 0.0015 versus
control, p% 0.0001 versus ACh). LPA effect, however, was
not affected by C3 but reduced by Y27632 (LPAþC3 ¼
5.35 1.4, p% 0.97 versus LPA, p% 0 .01 versus control;
LPAþY27632¼ 2.15 0.3, p% 0.07 versus LPA. P% 0.8
versus control). Importantly, C3 and Y27632 induced redis-
tribution of p-cofilin labeling, with reactivity concentrated
in the apical (hair bundle and cuticular plate) and basal
(nucleus and Retzius body, immediately below the nucleus)
regions of the cells (Fig. 1 D, center and right).ROCK/LIMK/cofilin-mediated signals regulate
OHC motility
To investigate the role of ROCK/LIMK/cofilin-mediated
signals in OHC motility we used the ROCK inhibitor
Y27632 and S3, a peptide corresponding to the first 16
amino acids of cofilin containing the LIMK phosphorylation
site at serine 3. This peptide binds to both LIMK1 and
LIMK2 competitively, inhibiting their ability to phosphory-
late cofilin (20).
A pure electromotile response, as confirmed by motility
analysis (21), was elicited by stimulating isolated OHCs
with single electrical pulses repeated every 2 min (Fig. 2 A).FIGURE 2 Role of cofilin phosphorylation on OHC electromotility (A) and s
Y27632-exposed (n ¼ 5) OHCs. (Ab) Electromotile amplitude in S3 (n ¼ 7) and
(Ac) NLC measurements, corresponding to single, representative cells, showing
length in control (n¼ 10) and Y27632-exposed (n¼ 14) OHCs. (Bb) Slow lengt
are the same that in panel Ba, and were included here for comparison. (Points
Biophysical Journal 99(7) 2067–2076In contrast to control cells, which exhibited a near-constant
response, OHCs exposed to Y27632 showed a significant
reduction in electromotile amplitude (p % 0.003, Y27632
group versus control group), with progressive impairment
starting <4 min after the start of the treatment (Fig. 2 Aa).
S3-loaded OHCs showed a similar decrease in electromotile
amplitude over time (p % 0.05, S3 versus control; see
Fig. 2 Ab). Electromotile amplitude did not decrease when
S3RV, a peptide with the same 16 amino acids but with
reverse sequence of S3, was used, confirming the effect
was specific. NLC measurements showed no effects of
Y27632 and S3 on prestin performance, indicating that the
changes in electromotile amplitude induced by the inhibi-
tors were not associated with the motor proteins (Fig. 2 Ac
and Table 1).
Cofilin inhibition also affected OHC slow motility
(Fig. 2 Ba). Control cells shortened rapidly and then stabi-
lized ~3 min after the establishment of the whole-cell
configuration, never recovering their original length. Cells
exposed to Y27632 showed similar changes, with no sig-
nificant differences between both groups (Fig. 2 Ba). Expo-
sure to S3, in contrast, abolished cell shortening associated
with establishment of whole-cell configuration, with OHCs
reaching approximately their original length at the end of
the experiment (p % 0.02 versus control. Fig. 2 Bb). The
small, transient cell contraction (<5%) observed immedi-
ately after membrane disruption was probably related tolow OHC motility (B). (Aa) Electromotile amplitude in control (n ¼ 5) and
S3RV-treated (n ¼ 4) OHCs. Control values are the same that in panel Aa.
no effects of treatment on Prestin performance. (Ba) Slow changes in total
h changes in OHCs exposed to S3 (n ¼ 6) and S3RV (n¼ 5). Control values
and vertical bars represent mean5 SE.)
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Cytoskeletal Regulation of OHC Motility 2071the time required for S3 to diffuse into the cells. No effects
were observed in cell exposed to S3RV.LIMK and cofilin mediate ACh and LPA effects on
OHC electromotility
Next, we examined the effects of ACh and LPA on OHCs
that were either untreated or exposed to Y27632 and S3.
Control cells showed an average electromotile amplitude
of 3.12% (relative to total cell length. Range 2.92–3.49%),
ACh increased this amplitude by 14–27%, with values
slightly fluctuating around an average of 3.84% (range
3.71–3.99%) over the 10 min experiment (Fig. 3 Aa). As
described in a previous report (6), ACh effect on OHCs
exposed to Y27632 consisted of a slight decrease in electro-
motile amplitude in the first 4 min, followed by a partial
recovery (Fig. 3 Aa). The response elicited by ACh in cells
exposed to S3, in contrast, was similar to that elicited by S3
alone, a continuous decrease in electromotile amplitude
with time (from 3.8% to 0.7%. Fig. 3 Aa). We also con-
firmed previous reports (6,9) showing that ACh does not
affect prestin function, as indicated by lack of changes in
NLC (inset, Fig. 3 Aa and Table 2).
Except for a dip at 4 min, exposure to LPA increased
OHC’s electromotile amplitude by 13–38% in a progressive
manner (average 4.1%, range 3.8–4.6%. Fig. 3 Ab). The
response of OHCs to LPAþY27632 or LPAþS3, in turn,
was similar to that elicited by Y27632 or S3 alone, indi-
cating that either ROCK inhibition or cofilin inhibition
were sufficient to completely block the stimulatory effect of
LPA on OHC electromotile amplitude. Interestingly, statis-
tical analysis indicated that OHCs responses to AChþS3
and LPAþS3 were similar, whereas responses to AChþ
Y27632 and LPAþY27632 showed a significant difference
(p % 0.0001). NLC measurements confirmed that neither
LPA alone nor combined with Y27632 or S3 influenced
prestin motor response, supporting the idea that the
observed effects were mediated by cytoskeletal changes
(inset, Fig. 3 Ba and Table 2).LIMK and cofilin also mediate ACh and LPA
effects on slow OHC motility
OHCs exposed to ACh shortened during the first 2 min, just
like control cells, but the peak contraction lasted only
~1 min and was followed by recovery (Fig. 3 Ab). This
response resembled the time course of the effects of ACh
perfusion on the displacement of the basilar membrane
measured at the basal turn of the guinea pig cochlea (24).
Interestingly, cells treated with AChþY27632 showed the
same response as control-cells, whereas cells exposed to
AChþS3 responded just like those treated with ACh alone.
Statistical analysis showed that the responses elicited by
ACh and AChþS3 were, on average, significantly differentBiophysical Journal 99(7) 2067–2076
FIGURE 3 Effect of ACh and LPA on OHCs
exposed to Y27632 and S3. (Aa) ACh effect on
electromotile amplitude of untreated cells (ACh,
n ¼ 8) and cells exposed to Y27632 (n ¼ 4) and
S3 (n ¼ 4). Data for control condition is the
same used in Fig. 2 Aa, and was included here for
comparison. (Inset) NLC measurements. (Ab) ACh
effect on slow motility of untreated cells (ACh,
n ¼ 8) and cells exposed to Y27632 (n ¼ 4) and
S3 (n ¼ 4). Data for control condition is the
same used in Fig. 2 Ba, and was included here
for comparison. (Ba and Bb) Same as for panels
Aa and Ab, but using LPA (n ¼ 5),
Y27632þLPA (n ¼ 6), and S3þLPA (n ¼ 7).
(Points and vertical bars represent mean5 SE.)
2072 Matsumoto et al.(p% 0.05) to those observed in control and AChþY27632-
exposed cells (Fig. 3 Ab). OHCs exposed to LPA,
LPAþY27632, and LPAþS3 showed a significant rebound
effect (p % 0.02 versus control) similar to that observed
in OHCs exposed to ACh and AChþS3 (Fig. 3 Ba). This
rebound effect was clearly distinct from the near asymptotic
decrease in length observed in cells exposed to Y27632
alone and the slight, but continuous increase in length dis-
played by OHCs exposed to S3 alone.Effect of latrunculin-A on isolated OHCs
We exposed isolated OHCs to latrunculin-A, an agent that
prevents actin monomers from polymerizing into filaments
(25), to investigate whether inhibition of actin polymeriza-
tion could ameliorate the effects of Y27632 and S3 on
OHC motility. We speculated that exposure to latrunculin-
A (decreasing actin polymerization) could somewhat
compensate the effects of Y27632 and S3 (decreasing actin
depolymerization). Interestingly, addition of nanomolar
concentrations of latrunculin-A to the external medium
induced a fast and irreversible failure of the OHC’s lateralTABLE 2 Effects of ACh and LPA on OHC’s nonlinear capacitance
Control
(n ¼ 4)
ACh
(n ¼ 4)
Vmax(mV) 38.45 6.8 NS (p ¼ 0.635) 40.25 6.
Cmax(pF) 45.35 2.4 NS (p ¼ 0.939) 45.05 1.
z 0.835 0.04 NS (p ¼0.999) 0.825 0.
Qmax(pC) 2.455 0.16 NS (p ¼ 0.996) 2.475 0.
Clin(pF) 24.15 0.9 NS (p ¼ 0.959) 23.95 0.
Vmax, voltage at peak capacitance; Cmax, peak capacitance; z, valence; Qmax, ma
Biophysical Journal 99(7) 2067–2076wall, with disruption of the plasma membrane followed by
cell death (Fig. 4 A). Perfusion experiments consistently
showed a fast disruption of cytoplasmic structures, followed
by cell elongation and ballooning of the basal region of the
OHCs. The plasma membrane was disrupted at the basal
region before the effects of the drug on the lateral wall
were apparent (Fig. 4, B and C). Latrunculin effects were
not prevented by previous perfusion of OHCs with S3
through the patch pipette. Thus, whereas actin depolymer-
ization may be important for regulating OHC motility, actin
polymerization seems to be crucial for maintaining OHC
shape and functionality.DISCUSSION
Previous studies have suggested that OHC motility is regu-
lated by cytoskeletal changes mediated by Rho GTPases,
but no details about the molecular targets of the Rho-medi-
ated signals were provided (5,6). Here, we present evidence
indicating that the regulatory mechanism relies, at least in
part, on the control of the depolymerization rate of actin fila-
ments by LIMK/cofilin-mediated signals.Control
(n ¼ 5)
LPA
(n ¼ 5)
6 44.35 4.2 NS (p ¼ 0.825) 45.15 3.0
8 43.35 2.2 NS (p ¼ 0.958) 43.25 2.6
05 0.855 0.04 NS (p ¼ 0.996) 0.835 0.04
09 2.315 0.19 NS (p ¼ 0.994) 2.295 0.20
8 22.85 0.7 NS (p ¼ 0.930) 23.15 0.7
ximum nonlinear charge moved; Clin, linear membrane capacitance.
FIGURE 5 Schematic model for the signaling pathways targeting cofilin
phosphorylation activated by ACh and LPA as suggested by results in this
article. The pathways putatively stimulated by ACh are highlighted in gray.
(EM, electromotility; SM, slow motility.)
FIGURE 4 Effect of latrunculin. (A) After the addition of 0.2 mM of
latrunculin-A to the external medium, the basal region of the OHCs expands
quickly, adopting a spherical shape (arrowhead), and then bursts, killing the
cell (arrow). (B) A typical cell immediately after attachment of a patch
pipette filled with latrunculin, and (C) moments later, showing latruncu-
lin-induced disruption of cytoplasmic structures, cell elongation, and
progressive ballooning of the basal part. All cells died before the membrane
was ruptured to establish whole-cell configuration.
Cytoskeletal Regulation of OHC Motility 2073ACh and LPA induce cofilin phosphorylation
via different pathways
Our results indicate both ACh and LPA induce LIMK-medi-
ated-cofilin phosphorylation, therefore decreasing the rate
of actin depolymerization, but they achieve this effect
by activating different signaling pathways. Whereas ACh
uses a RhoA-dependent (C3-sensitive), ROCK-independent
(Y27632-insensitive) signaling cascade, LPA would phos-
phorylate cofilin via either RhoA/ROCK or a different path-
way involving neither RhoA nor ROCK (Fig. 1, C and D).
Activation of ACh receptors in OHCs leads to an increase
in intracellular Ca2þ and the opening of small conductance
Ca2þ-activated Kþ channels (26). It has already been sug-
gested that a Ca2þ-dependent pathway activated by ACh
would target proteins in the OHC cytoskeleton (9). Interest-
ingly, studies in endothelial (27) and smooth muscle cells
(28,29) suggest that increasing levels of intracellular Ca2þ
induced by agonist stimulation could led to direct activationof Rho GTPases by facilitating selective translocation
of inactivated RhoA to the plasma membrane, where it
becomes available for activation (29). Thus, we speculate
that a similar mechanism could be at work in OHCs, with
ACh-induced RhoA signals activating LIMK either via
ROCK- or Rac1/Cdc42-mediated pathways (Fig. 5).
The effects of C3 and Y27632 on LPA-induced cofilin
phosphorylation (Fig. 1 D) could be explained by our find-
ing that guinea pig OHCs express two types of LPA recep-
tors, LPA1 and LPA4 (Fig. 1 B). It has been reported that, in
a rat neuronal cell line, LPA could stimulate a Rac-depen-
dent pathway via LPA1 and a RhoA/ROCK-dependent
pathway via LPA1/LPA4 (30). Thus, we speculate some-
thing similar could be occurring in OHCs, with LPA-
induced cofilin phosphorylation being mediated by different
signaling pathways associated, respectively, with LPA1 and
LPA4.Subcellular distribution suggests different
functional roles for LIMK1 and LIMK2 in guinea
pig OHCs
Although LIMK1 and LIMK2 are very homologous, there is
increasing evidence that each may be subject to different
regulatory pathways and may contribute to both distinct
and overlapping cellular functions (11). The different distri-
bution of LIMK1 and LIMK2 in guinea pig OHCs, and the
existence of at least two specific signaling pathways able to
induce LIMK-mediated cofilin phosphorylation, strongly
supports this idea. The presence of cofilin and LIMK2—
but not LIMK1—in the hair bundle of isolated OHCs, andBiophysical Journal 99(7) 2067–2076
2074 Matsumoto et al.the failure of C3 and Y27632 in preventing LPA-induced
cofilin phosphorylation there (Fig. 1 D), suggests that cofi-
lin-induced actin depolymerization in the stereocilia would
be controlled by a RhoA/ROCK-independent, LIMK2-
mediated signals. LIMK1 and RhoA/ROCK-dependent sig-
nals, on the other hand, could be more directly associated
with OHC motility, because both electromotility and slow
motility are mechanical responses involving the OHC’s
main body.Cofilin phosphorylation is a major regulator
of OHC electromotility
The decrease in electromotile amplitude induced by Y27632
in nontreated and LPA-exposed OHCs (Figs. 2 Aa and 3 Ba)
confirmed previous results from our laboratory, suggesting
involvement of a RhoA/ROCK-mediated pathway in the
regulation of prestin-dependent OHC motility (6). We have
further extended these results by demonstrating that com-
plete inhibition of cofilin phosphorylation with S3 induced
an identical response in cells stimulated with LPA and
ACh, whereas Y27632 effects were overridden by ACh
but not by LPA. These results lead to two significant conclu-
sions: first, signals mediated by the RhoA/ROCK/LIMK/
cofilin pathway are sufficient to explain all observed effects
of LPA on OHC electromotility, and second, cofilin phos-
phorylation induced by activation of a ROCK-independent
pathway is sufficient to explain all observed effects of
ACh on OHC electromotility.
We can envision a scenario where OHC electromotile
amplitude is maintained at an optimal level by a very sensi-
tive mechanism largely based on cofilin-regulated actin
depolymerization. A large pool of cofilin would be normally
phosphorylated (see Fig. 1 A), keeping the rate of actin
depolymerization low and electromotile amplitude high.
LPA stimulation, however, would still be able to increase
electromotility amplitude via overactivation of an already
functional RhoA/ROCK/LIMK/cofilin signaling pathway.
The signals generated by LPA would phosphorylate more
cofilin, increasing stability of actin filaments and the actin-
based cortical cytoskeleton by inhibiting actin depolymer-
ization. Inhibition of ROCK, in turn, would increase the
rate of actin depolymerization by inhibiting cofilin phos-
phorylation, with a consequent disruption in cortical cyto-
skeleton structure and significant decrease in electromotile
amplitude because of inefficient harnessing of the forces
generated by prestin molecules in the lateral plasma mem-
brane. ACh, on the other hand, would be able to inhibit actin
depolymerization by phosphorylating cofilin via ROCK-
independent pathway/s, returning electromotile amplitude
to normal values. Thus, ACh would be working as a fast-
reset mechanism as suggested in a previous model (6).
In contrast to the previous model, however, rather than
inhibiting a putative Rac-mediated signaling pathway aimed
at decreasing OHC electromotile amplitude, ACh wouldBiophysical Journal 99(7) 2067–2076be stimulating that pathway to phosphorylate cofilin,
bypassing the ROCK-dependent regulatory mechanism
(Fig. 5). In addition, our results also indicate a minimal—
if any—contribution of alternative ROCK-mediated signals
targeting the cytoskeleton (not involving LIMK-mediated
cofilin phosphorylation, e.g., a RhoA/ROCK/adducin cas-
cade (6)) to the regulation of OHC electromotility.Cofilin phosphorylation is also involved
in the regulation of OHC slow motility
Exposure to S3, but not to Y27632, abolished cell short-
ening linked to the establishment of the whole-cell patch
configuration (Fig. 2, Aa and Ab). Thus, we can hypothesize
that this contraction is associated with cofilin phosphoryla-
tion mediated by a ROCK-independent mechanism. More-
over, the similar inhibition of cell shortening induced by
LPA and LPAþY27632 (Fig. 3 Bb) suggest that LPAwould
also be able to inhibit cofilin phosphorylation via a ROCK-
independent mechanism. Thus, our results not only provide
evidence that LPA could be able to stimulate two different
signaling pathways in guinea pig OHCs, but suggest that
LPA would be regulating OHC electromotility by stimu-
lating cofilin phosphorylation via a ROCK-dependent path-
way, and regulating OHC slow motility by inhibiting cofilin
phosphorylation via a ROCK-independent pathway (Fig. 5).
ACh, on the other hand, would affect OHC motility just
like LPA but via different pathways. The similar effects of
ACh alone and AChþS3 on slow motility suggest that
ACh inhibits cofilin phosphorylation, whereas the response
to AChþY27632 suggests that this effect would be medi-
ated by ROCK. Thus, ACh would be regulating OHC elec-
tromotility by stimulating cofilin phosphorylation via a
ROCK-independent pathway, and regulating OHC slow
motility by inhibiting cofilin phosphorylation via a ROCK-
dependent pathway (Fig. 5).How does cofilin phosphorylation translate
into regulation of OHC motor function?
The results here, showing that S3, LPA, and ACh do not
change the capacitance-voltage function of prestin, make
unlikely a direct effect of LIMK/cofilin-mediated signals
on the motor protein. The amplitude of OHC electromotility,
however, relies not only on prestin performance but also on
the effective harnessing of the individual forces generated
by prestin molecules in the plane of the membrane (3,4).
Thus, the well-known effects of LIMK/cofilin-mediated
signals on actin dynamics strongly support the idea that
the actin-based cytoskeleton could play a central role in
the regulation of prestin-dependent OHC electromotility.
We speculate that LIMK/cofilin-mediated signals would
regulate the length and distribution of actin filaments in
the OHC cortical cytoskeleton, modulating the magnitude
of the vectorial component of the prestin-generated forces
Cytoskeletal Regulation of OHC Motility 2075in the plasma membrane along the longitudinal axis of the
OHCs.
While prestin-dependent motility is unique to OHCs,
every cell is able to change its shape in response to specific
signals in a process involving active reorganization of the
actin cytoskeleton. Slow OHC motility requires a correct
spatial and temporal assembly and disassembly of actin.
Thus, control of LIMK-mediated cofilin phosphorylation
is a natural regulatory mechanism of OHC shape. Because
the micromechanics of the cochlear partition depends criti-
cally on the length of the OHCs, slow motility regulation
could have a profound influence on cochlear amplification.
In particular, the proposed ability of the efferent feedback
to protect the cochlea from noise trauma (31) could be asso-
ciated with the effect of ACh on OHC slow motility rather
than electromotility. Electrical stimulation of medial olivo-
cochlear fibers result in release of ACh from the end termi-
nals at the base of cochlear OHCs, and the major effect is
a reduction in cochlear amplification by some 20 dB (7).
However, the reported increase in OHC electromotile ampli-
tude induced by ACh ((8,9) and this report) is contrary to the
expected inhibitory response. These results could be concil-
iated, assuming ACh-induced slow changes in OHC length
as the most important mechanical effect of efferent stimula-
tion. OHC elongation, for instance, might increase the depth
of the subtectorial space, changing its hydrodynamic prop-
erties and diminishing the gain of the cochlear amplifier
by affecting the stimulation of the IHC’s stereocilia by fluid
flow (32). This speculation is consistent with previous
results from other laboratories showing that ACh stimulates
a Ca2þ-dependent pathway targeting the OHC cytoskeleton
(9), and that in vivo perfusion of ACh in the guinea pig
cochlea induces a measurable displacement of the basilar
membrane with the same time course of the slow changes
in OHC length reported in this study (24).CONCLUSIONS
The rate of actin depolymerization, as regulated by LIMK-
mediated cofilin phosphorylation, would be pivotal for the
motile response of cochlear OHCs. The amplitude of the
electromotile response is associated to the available amount
of nonphosphorylated (active) cofilin. LIMK-mediated con-
trol of cofilin phosphorylation would regulate the rate of
depolymerization of actin filaments, the stability of the
cortical cytoskeleton, and, consequently, OHC electromotile
amplitude and total length. LPA works as an exogenous
agonist for the electromotile process by overactivating
a RhoA/ROCK/LIMK-mediated pathway able to induce
cofilin phosphorylation, and influencing OHC slow motility
by stimulating a ROCK-independent pathway inhibiting
cofilin phosphorylation. ACh is able to stimulate cofilin
phosphorylation and OHC electromotility via a RhoA-
dependent, ROCK-independent signaling cascade, and
modulate OHC slow motility by inhibiting cofilin phosphor-ylation via RhoA/ROCK. This regulation of cell length and
electromotile amplitude could have profound influence on
the gain of the cochlear amplifier.SUPPORTING MATERIAL
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